Wnt pathway in atypical teratoid rhabdoid tumors

Madhavi Chakravadhanula1, Chris N Hampton1, Parth Chodavadia1

  • 1Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, Arizona (M.C., C.N.H., V.O., R.D.B.); Children's Hospital at Westmead, Sydney, Australia (L.Z., D.C.); Duke University, Durham, North Carolina (P.C.); Children's Hospital Los Angeles, Los Angeles, California (A.E.-E.); Children's Hospital Los Angeles and the University of Southern California, Los Angeles, California (J.X., A.E.-E.).

Neuro-Oncology
|September 24, 2014
PubMed
Abstract

Insights

Wnt5B ligand is upregulated in atypical teratoid rhabdoid tumors (ATRTs), a pediatric brain cancer. Inhibiting Wnt5B and its receptors shows promise for new ATRT therapies.

Area of Science:

  • Pediatric oncology
  • Molecular biology
  • Cancer research

Background:

  • Atypical teratoid rhabdoid tumor (ATRT) is a rare and aggressive pediatric brain tumor.
  • Current therapeutic strategies for ATRT are limited, necessitating novel treatment approaches.

Purpose of the Study:

  • To investigate the role of the Wnt signaling pathway, specifically the Wnt5B ligand, in ATRT biology.
  • To analyze the expression of WNT5B and other Wnt pathway genes in ATRT tissues and cell lines.

Main Methods:

  • Transcriptome sequencing (nanoString)
  • Immunohistochemistry
  • Western blotting
  • Quantitative reverse transcriptase PCR
  • Immunoprecipitation
  • Short interference RNA (siRNA) studies
  • Cell viability assays
  • Drug dose response (DDR) assays

Main Results:

  • WNT5B gene expression is significantly upregulated in ATRT samples compared to non-tumor brain tissue.
  • Wnt5B was found to bind to Frizzled1 and Ryk receptors.
  • Inhibition of WNT5B via siRNA reduced Frizzled1 and Ryk expression.
  • Inhibiting the Frizzled1 receptor significantly decreased ATRT cell viability.
  • Drug dose response assays indicated potential efficacy of certain inhibitors.

Conclusions:

  • The Wnt5B pathway plays a significant role in ATRT pathogenesis.
  • Targeting WNT5B and its associated receptors presents a promising therapeutic strategy for ATRT.
  • Further research and clinical trials are warranted to translate these findings into effective patient treatments.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

1.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

1.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K